ARCHIVES

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

This article is from The Cancer Letter archive.

Vol. 12 No. 11 | March 14, 1986

Download PDF Visit The Full Archive

Related Articles

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

Advocacy. Bypass Budget Treated As Serious Funding Request By Advocates

January 30, 1998

NCI, NIH Make Half-Hearted Pitch For Cancer Act Before Seemingly Uninterested Rogers Committee

March 10, 1978

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003

Fischinger Names HHS AIDs Coordinator; DeVita Appoints Maryann Roper Acting Deputy Director

October 30, 1987